Thyrocare Technologies Q4 FY25 consolidated PAT up at Rs. 21.70 Cr
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Thyrocare Technologies has reported total income of Rs. 179.97 crores during the period ended September 30, 2024
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
The company has posted net profit of Rs.70.76 crores for the Financial Year ended March 31, 2024
Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated